Survival outcomes for patients with surgically induced end-stage renal disease

Bimal Bhindi, Dennis Asante, Megan E. Branda, La Tonya J. Hickson, Ross J. Mason, Molly M. Jeffery, Stephen A. Boorjian, Bradley C. Leibovich, R. Houston Thompson

Research output: Contribution to journalArticle

Abstract

Introduction: While medically induced end-stage renal disease (m-ESRD) has been well-studied, outcomes in patients with surgically induced ESRD (s-ESRD) are unknown. We sought to quantitatively compare the non-oncological outcomes for s-ESRD and m-ESRD in a large population-based cohort. Methods: Medicare patients >65 years old initiating hemodialysis were identified using the U.S. Renal Data System database (2000-2012). Metastatic cancer, prior transplant history, and nephrectomy for polycystic kidney disease were exclusion criteria. Patients were classified as having s-ESRD or m-ESRD based on hospital and physician claims for nephrectomy within a year preceding the onset of maintenance hemodialysis. Outcomes included non-cancer mortality (NCM), overall survival (OS), cardiovascular event (CVE), and renal transplantation. Time-to-event analyses were performed using Kaplan-Meier and cumulative incidence curves, and multivariable Cox and Fine-and-Grey regression models. Results: The cohort included 312 612 patients, of whom 1648 (0.53%) had s-ESRD. Compared to m-ESRD patients, s-ESRD patients had a significantly lower five-year cumulative incidence of NCM (68% vs. 80%; p<0.001) and CVE (62% vs. 68%; p<0.001), with a correspondingly higher probability of OS (22% vs. 17%; p<0.001) and rate of renal transplantation (3.6% vs. 2.0%; p<0.001). On multivariable analyses, s-ESRD remained associated with lower risks of NCM (p<0.001) and CVE (p<0.001), improved OS (p<0.001), and higher chance of renal transplantation (p<0.001). Conclusions: While outcomes for s-ESRD appear more favorable than m-ESRD, s-ESRD is still associated with a substantial risk of NCM and CVE, and a low incidence of renal transplantation in Medicare patients >65 years old. These non-oncological outcomes are worth considering in patients potentially facing postoperative ESRD.

Original languageEnglish (US)
Article number6010
JournalCanadian Urological Association Journal
Volume14
Issue number3
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Survival outcomes for patients with surgically induced end-stage renal disease'. Together they form a unique fingerprint.

  • Cite this

    Bhindi, B., Asante, D., Branda, M. E., Hickson, L. T. J., Mason, R. J., Jeffery, M. M., Boorjian, S. A., Leibovich, B. C., & Thompson, R. H. (2020). Survival outcomes for patients with surgically induced end-stage renal disease. Canadian Urological Association Journal, 14(3), [6010]. https://doi.org/10.5489/cuaj.6010